In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Seeking the Gold Dies at 31
- Little Mike Retired to Old Friends
- Connect Leads 1-2 Finish for Brown in Curlin
- Borell Arraignment Set for Aug. 1
- Full Field Possible for West Virginia Derby
- American Cleopatra Entered at Del Mar
- Champion Tepin Will Bypass Fourstardave
- Nyquist, Exaggerator Renew Rivalry in Haskell
- Arlington, Hawthorne Reach Dates Agreement
- Thunderstorm Forces Ellis to Cancel Races